Pulmonary complications after cardio-thoracic surgery increase mortality and morbidity, hospital length of stay and costs. Adequate drainage of the pleural space from air (and fluid) is the cornerstone of good management.

While several chest drainage systems are commercially available worldwide, their performances vary and are suboptimal in certain patients. Furthermore, not only is true investigation of the principles by which they work sparse but also many doctors still rely on knowledge that is based on empirical observations rather than on substantial scientific evidence.

The BreatheCoreTM monitoring system offers real-time, patient-specific, data analytics capable to predict post-operative complications following cardio-thoracic surgery. For the first time, surgeons can offer custom chest drainage therapy to patients and therefore maximize their recovery. This will improve patient safety & quality care, positively affecting hospital revenues.

Unmet Clinical Need and Market

In carrying out the preliminary work that is the basis for the BreatheCore monitoring system, the simplistic nature of pleural space management and its consequences have been highlighted. Furthermore, thoracic surgical patients encompass a wider spectrum of diseases than what was previously considered feasible, e.g. surgery is now offered more often to patients with end-stage fibrosis or emphysema. Nevertheless, these are high-risk patients and, as such, should be considered for tailored chest drainage therapies. Until now, the market lacked a system capable of doing this.